Kodchawan Doungsong

Ms. Kodchawan Doungsong

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in Osteoporosis International
Verified
Journal Article
Open access
PDF file
KDKodchawan Doungsong
Kodchawan Doungsong
JDJacob Davies
Jacob Davies
VEVictory Ezeofor
Victory Ezeofor
Llinos Haf SpencerLlinos Haf Spencer
Llinos Haf Spencer
NWNefyn Williams
Nefyn Williams
OTon behalf of the FEMuR III team
on behalf of the FEMuR III team
Summary The FEMuR III economic evaluation presents costs and consequences of the intervention compared with usual care at 52-week follow-up. There was no evidence of clinical effectiveness in terms of improvement of quality of life, and the total health service costs were higher in the intervention group. Purpose To explore the costs and consequences of the new FEMuR III intervention compared to usual care after hip fractures. Methods This cost-consequence analysis accompanies the FEMuR III randomised controlled trial using a micro-costing approach. The main outcome measures in this economic evaluation were healthcare service use, costs, and quality of life over 12 months, from both National Health Service and wider societal perspectives. Quality of life was measured using the EuroQoL-5D-3L. Results The mean cost of delivering the intervention was £444 per participant. For participants with complete EQ-5D data (n = 142), both groups showed improvement in EQ-5D index score, moving scores closer to UK norms. Participants in the intervention group gained 0.02 (95% CI: − 0.036, 0.076) more quality-adjusted life years (QALYs) than the usual care group. However, this was not statistically significant (p value = 0.312). For imputed cases, participants in the intervention group gained less QALYs than the usual care by 0.01 (95% CI: − 0.056, 0.030). For participants with complete cost data (n = 115), at 52-week follow-up, mean health service use costs were higher in the intervention group from both perspectives. Conclusions The mean health service use costs were higher in the intervention group due to longer inpatient stays. There was no significant difference in QALYs between both groups. The trial was affected by the COVID-19 pandemic, and this goes some way to explaining the large proportion of missing data (40%). Trial registration ISRCTN28376407.

1 January 2024 in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
Verified
Journal Article
Open access
KDKodchawan Doungsong
Kodchawan Doungsong
NHNed Hartfiel
Ned Hartfiel
JGJohn Gladman
John Gladman
RHRowan Harwood
Rowan Harwood
RERhiannon Tudor Edwards
Rhiannon Tudor Edwards
Regular exercise and community engagement may slow the rate of function loss for people with dementia. However, the evidence is uncertain regarding the cost-effectiveness and social return on investment (SROI) of home exercise with community referral for people with dementia. This study aimed to compare the social value generated from the in-person PrAISED program delivered before March 2020 with a blended PrAISED program delivered after March 2020. SROI methodology compared in-person and blended delivery formats of a home exercise program. Stakeholders were identified, a logic model was developed, outcomes were evidenced and valued, costs were calculated, and SROI ratios were estimated. Five relevant and material outcomes were identified: 3 outcomes for patient participants (fear of falling, health-related quality of life, and social connection); 1 outcome for carer participants (carer strain), and 1 outcome for the National Health Service (NHS) (health service resource use). Data were collected at baseline and at 12-month follow-up. The in-person PrAISED program generated SROI ratios ranging from £0.58 to £2.33 for every £1 invested. In-person PrAISED patient participants gained social value from improved health-related quality of life, social connection, and less fear of falling. In-person PrAISED carer participants acquired social value from less carer strain. The NHS gained benefit from less health care service resource use. However, the blended PrAISED program generated lower SROI ratios ranging from a negative ratio to £0.08:£1. Compared with the blended program, the PrAISED in-person program generated higher SROI ratios for people with early dementia. An in-person PrAISED intervention with community referral is likely to provide better value for money than a blended one with limited community referral, despite the greater costs of the former. Trial registration: ISRCTN Registry ISRCTN15320670.

15 August 2025 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
PMPatricia Masterson-Algar
Patricia Masterson-Algar
FIFatene Abakar Ismail
Fatene Abakar Ismail
BABethany Anthony
Bethany Anthony
MCMaria Caulfield
Maria Caulfield
JCJohn Connaghan
John Connaghan
GWGill Windle
Gill Windle
Supporting dementia carers is a global priority. As a Randomised Controlled Trial (RCT) (n = 352) of the Word Health Organization recommended, an internationally disseminated ‘iSupport’ e-health intervention was conducted, revealing no measurable benefits to the wellbeing of adult dementia carers. This process evaluation contributes original insights of the trial outcomes. Its aims were to ascertain the usability and acceptability of iSupport, participant engagement and adherence to iSupport, and contextual factors influencing its implementation and potential impact. The process evaluation followed a mixed-method design. The following data were collected from all participants randomised to iSupport (n = 175): (1) post-intervention evaluation questionnaire (n = 93) containing the 10-item System Usability Scale and bespoke items exploring acceptability, engagement, and perceived impact; (2) qualitative interviews (n = 52) with a sub-sample of participants who were purposively sampled according to age, scores on the outcome measures, and gender, as these interviews aimed to generate contextual detail and explanatory accounts; and (3) ‘Access’ data from the iSupport platform (n = 175). Descriptive statistics was used to report on the frequency of survey responses whilst a thematic analysis approach was followed to identify themes from the qualitative interview data. Data sets were analysed independently and then used with respect to one another in order to generate explanatory pathways related to the usability, acceptability, and the impact of iSupport. Despite good trial retention, 8.3% of participants (n = 32) did not spend any time on iSupport, and 54% (n = 94) spent between 30 min and 1.5 h. Factors driving this were the following: time constrains, method of delivery, and content characteristics. Positive impacts of iSupport were also described. Participants, including those with extensive caring experience, reported how iSupport had made them feel reassured, valued, and more able to ask for help. They also reported having an improved outlook on their caring role and on the needs and feelings of the person living with dementia. Research and practice should focus on exploring blended delivery, including self-directed and interactive components, such as regular contact with a health professional. These insights are critical for supporting the global implementation and adaptation of iSupport and offer valuable directions for future research.

25 August 2023 in medRxiv
Verified
Preprint
Open access
PDF file
KDKodchawan Doungsong
Kodchawan Doungsong
NHNed Hartfiel
Ned Hartfiel
JGJohn Gladman
John Gladman
RHRowan H Harwood
Rowan H Harwood
RERhiannon Tudor Edwards
Rhiannon Tudor Edwards
Background: Regular exercise and community engagement may slow the rate of function loss for people with dementia. However, the evidence is uncertain regarding the cost-effectiveness and social return on investment (SROI) of home exercise with community referral for people with dementia. This study aimed to compare the social value generated from the in-person PrAISED programme delivered before March 2020 with a blended PrAISED programme delivered after March 2020. Methods: SROI analysis was conducted alongside a randomised controlled trial (RCT). Of 205 patient participants and their carers who completed cost data, 61 completed an in-person programme before March 2020. Due to COVID-19 pandemic restrictions, 144 patient participants completed a blended programme consisting of a combination of in-person visits, phone calls and video conferencing with multidisciplinary team (MDT) members. SROI analysis compared in-person and blended delivery formats. Five relevant and material outcomes were identified: three outcomes for patient participants (fear of falling, health-related quality of life, and social connection); one outcome for carer participants (carer strain index), and one outcome for the NHS (health service resource use). Data were collected at baseline and a 12-month follow-up. Results: The in-person PrAISED programme generated SROI ratios ranging from £0.58 to £2.33 for every £1 invested. In-person PrAISED patient participants gained social value from improved health-related quality of life, social connection, and less fear of falling. In-person PrAISED carer participants acquired social value from less carer strain. The NHS gained benefit from less health care service resource use. However, the blended PrAISED programme generated lower SROI ratios ranging from a negative ratio to £0.08: £1. Conclusion: Compared with the blended programme, the PrAISED in-person programme generated higher SROI ratios for people with early dementia. During the COVID-19 pandemic and its restrictions, a blended delivery of the programme and the curtailment of community activities resulted in lower SROI ratios during this period. An in-person PrAISED intervention with community referral is likely to provide better value for money than a blended one with limited community referral, despite the greater costs of the former. Trial registration: ISRCTN15320670

16 January 2025 in medRxiv
Verified
Preprint
Open access
PDF file
Llinos Haf SpencerLlinos Haf Spencer
Llinos Haf Spencer
KDKodchawan Doungsong
Kodchawan Doungsong
MAMohammed Albustami
Mohammed Albustami
SDShanaz Dorkenoo
Shanaz Dorkenoo
RERhiannon Tudor Edwards
Rhiannon Tudor Edwards
NWNefyn Williams
Nefyn Williams
Background: Proximal femoral or hip fracture is a common problem among older adults. With an increase in patients with hip fracture comes and increase in the number of patients who require post-surgery rehabilitation. Our aim was to review effectiveness of rehabilitation after hip fracture studies. Methods: For this rapid review (RR) four databases, PubMed, PsycInfo, CINAHL and Cochrane Library, were searched for studies published between 1 st January 2017 and 15 th May 2023. The population were: people with hip fracture. Interventions: any hospital or community-based hip rehabilitation. Comparisons: improvements in function, and the outcomes were: physical function, quality of life and cost. Findings: Six studies were included in this RR which focussed on hip fracture rehabilitation programmes published since 2017. The studies were conducted in North America (USA), Europe (Germany, Austria, and Switzerland) and Asia (Hong Kong and China). Some randomised controlled trials and some cohort studies found beneficial effects of rehabilitation for older people who had undergone hip replacement treatments. The length of follow-up period ranged from 15 days to one year after surgery. Even though psychological distress, including loss of confidence and frustration, was the most important predictor of depression and anxiety in patients with hip fractures, only one study assessed anxiety and depression status of patients after surgery. It was not possible to combine the results in a meta-analysis as all the studies had different follow-up periods and used different outcome measures. Interpretation: The goal of achieving personalised rehabilitation treatment is possible and this concept of goal directed personalised rehabilitation should be developed and economically evaluated further. A strength of this review is that robust, recent, and relevant papers regarding rehabilitation following hip replacement were found and described. However, the main limitations were that none of the included studies conducted a cost-analysis of the intervention that they described, and no UK based study was included.

30 October 2026 in Clinical Rehabilitation
Verified
Journal Article
Open access
FRFiona J Rowe
Fiona J Rowe
JDJacob Davies
Jacob Davies
KDKodchawan Doungsong
Kodchawan Doungsong
EBElla Brayshaw
Ella Brayshaw
MBMichaela Brown
Michaela Brown
RERhiannon Tudor Edwards
Rhiannon Tudor Edwards
Objective: To explore the cost-effectiveness of visual scanning training for hemianopia compared to sham training. Design: Randomised controlled trial. Setting: Acute stroke unit and outpatient eye clinics. Participants: Adult stroke survivors with homonymous hemianopia. Intervention: Visual scanning training. Comparator: Sham eye pursuit movements. Main measures: Cost-utility and cost-effectiveness analyses were conducted from UK National Health Service (NHS) and wider societal perspectives. The primary analysis was a cost-utility analysis using EQ-5D-5L utility values. Cost-effectiveness analyses using changes in National Eye Institute-Visual Function Questionnaire-25 item composite and Brain Injury-associated Visual Impairment-Impact Questionnaire scores formed the secondary analyses. Results: Both intervention and sham training packages cost £9.58 (printing costs, clinician time to explain self-administration). Mean total health resource use costs at 26-weeks were higher in the intervention (£1406) than in the sham group (£1339). At 26-weeks, the intervention group gained 0.001 (95%CI:-0.018, 0.021) Quality-Adjusted Life Years (QALY) while the sham group evidenced a QALY loss of −0.002 (95%CI:-0.017, 0.012); not statistically significant (p = 0.71). The Incremental Cost-Effectiveness Ratio of visual scanning training compared to sham was £19,790/QALY, below the National Institute for Health and Care Excellence (NICE) threshold of £20,000–£30,000/QALY. Sensitivity analysis (5000 replications) suggested potential cost-effectiveness of visual scanning training, which had a 67% probability of being cost-effective at £20,000/QALY; this was not significant. Conclusions: This is the first economic evaluation comparing visual scanning training to sham training for treating post-stroke hemianopia. While both interventions had similar costs, the costs were slightly under NICE thresholds. The intervention evidenced marginal but non-significant QALY gain over sham.